Prelude Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everybody. Welcome to Barclays Global Healthcare Conference Day 2. My name is Peter Lawson. I'm one of the biotech analysts at Barclays. And I just wanted to thank everyone for joining us this morning, taking time out of their day. And if you have questions, institutional investors can e-mail me at [email protected] or ping me on Bloomberg. But it gives me great pleasure to introduce the management team from Prelude. And this morning, I've got with me Kris Vaddi, CEO; Brian Piper, CFO; and also have Chris Pierce, Chief Business Operations as well.
Questions & Answers
And just as a starting question I've been asking all our companies this kind of -- there's a lot of oncology companies, what's Prelude's point of differentiation and core competency within the space?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |